Heterotopic heart transplant combined with postoperative Sildenafil use for the treatment of restrictive cardiomyopathy

Abdulaziz Al-Khaldi; Bruce A Reitz; Henry Zhu; David Rosenthal

doi:10.1016/j.athoracsur.2005.02.069

Heterotopic heart transplant combined with postoperative Sildenafil use for the treatment of restrictive cardiomyopathy

Ann Thorac Surg. 2006 Apr;81(4):1505-7. doi: 10.1016/j.athoracsur.2005.02.069.

Authors

Abdulaziz Al-Khaldi¹, Bruce A Reitz, Henry Zhu, David Rosenthal

Affiliation

¹ Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, California, USA.

PMID: 16564308
DOI: 10.1016/j.athoracsur.2005.02.069

Abstract

We report successful management of a 22-month-old child with restrictive cardiomyopathy and severe pulmonary hypertension using the heterotopic heart transplant technique. Additional lessons learned from postoperative management, including the novel use of Sildenafil (Viagra, Pfizer, NY) for controlling pulmonary arterial pressure are described.

Publication types

Case Reports

MeSH terms

Cardiomyopathy, Restrictive / therapy*
Combined Modality Therapy
Female
Heart Transplantation / methods*
Humans
Infant
Piperazines / therapeutic use*
Postoperative Care
Purines
Sildenafil Citrate
Sulfones
Transplantation, Heterotopic
Vasodilator Agents / therapeutic use*

Substances

Piperazines
Purines
Sulfones
Vasodilator Agents
Sildenafil Citrate